Clinical Trials@2x
  • News

    Most Read

    • Reify Health extends StudyTeam platform availability for clinical trials
    • Forma doses first patient in Phase I prostate cancer treatment trial
    • BrainStorm’s Covid-19 ARDS treatment improves lung function in study

    Most Recent

    Clinical Research

    Reify Health extends StudyTeam platform availability for clinical trials

    21 Jan 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy
    • Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market
    • Novo Nordisk’s makes strides into Alzheimer’s with anti-diabetic drug

    Most Recent

    Clinical Trials

    Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy

    12 Jan 2021
  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • Reify Health extends StudyTeam platform availability for clinical trials
    • Forma doses first patient in Phase I prostate cancer treatment trial
    • Lack of specific skills and talents main obstacle to digital transformation: Survey

    Most Recent

    Clinical Research

    Reify Health extends StudyTeam platform availability for clinical trials

    21 Jan 2021
  • Themes
  • Deals

    Most Read

    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink
    • IVI and SNU partner to trial Inovio’s Covid-19 vaccine in Korea

    Most Recent

    Clinical Trials

    Investment firm GI Partners closes Clinical Ink acquisition

    27 Aug 2020
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Linari NanoTech
    • OpenClinica
    • Strategikon Pharma

    Most Recent

    Linari NanoTech

    19 Jan 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register

Victoria Smith

10 Sep 2020
Sponsored

Outsourcing in Clinical Trials USA – A Virtual Experience

10 Sep 2020
10 Sep 2020
Sponsored

Clinical Trial Supply 2020 – A virtual conference

10 Sep 2020
02 Jul 2020
Uncategorized

FDA may be risk-averse to grant emergency use for a Covid-19 vaccine; political pressure and hazy EUA standards are factors

02 Jul 2020
26 Jun 2020
Uncategorized

Gilead’s remdesivir to commence Phase I trials as inhaled therapy to target mild Covid-19 patients

26 Jun 2020
25 Jun 2020
Uncategorized

Dexamethasone, an unexpected drug, shows promise in treating Covid-19

25 Jun 2020
23 Jun 2020
Uncategorized

CanSino’s, J&J’s Covid-19 vaccines may be stifled by pre-existing antibodies while AstraZeneca’s, ReiThera’s may need booster

23 Jun 2020
18 Jun 2020
Uncategorized

The UK leads Covid-19 clinical investigations in Europe

18 Jun 2020
18 Jun 2020
Uncategorized

Myovant’s Phase III relugolix trial’s cardiovascular event reduction trend inconclusive

18 Jun 2020
18 Jun 2020
Uncategorized

AstraZeneca’s Tagrisso divides on immediate adoption in adjuvant non-small cell lung cancer

18 Jun 2020
15 Jun 2020
Uncategorized

Long-term efficacy data shows MDMA is effective for treating PTSD

15 Jun 2020

Join Our Newsletter

Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Clinical Trials

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more